Sunbird Bio's mission is to address the growing need for reliable and accessible diagnostic tests for neurological diseases which can accelerate drug development and enhance patient care.  The company was founded on technologies originating from the laboratory of our Chief Scientific Officer, Huilin Shao, a distinguished presidential professor at the National University of Singapore.  The company was formed after a landmark paper was published demonstrating the biological breakthrough that extracellular vesicles (EVs) from the brain carry sticky proteins through the blood-brain barrier and reflect the state of protein aggregation in the brain.  We have been developing a series of innovations to enable direct (purification-free) measurements of EV bound neurological biomarkers in the blood.  This funding will be used to accelerate the development of a quantitative blood based alpha synuclein assay.